Septodont Acquires Biomedical Tissues
We are delighted to announce that Septodont has completed the acquisition of Biomedical Tissues (BMT), a French MedTech company at the forefront of tissue engineering. The company designs, produces, and commercializes implantable membranes for tissue regeneration. Located in Nantes (western France) and founded ten years ago by a team of R&D scientists, the company uses a unique patented technology to manufacture synthetic microfib...Learn more
A proud moment for Septodont
Olivier Schiller, CEO of the Septodont Group, has won the EY Entrepreneur of the Year award 2022 for Ile-de-France in the Family Business category. The EY regional Entrepreneur of the Year award recognizes Septodont’s entrepreneurial achievements under Olivier Schiller’s leadership and the group’s ability to build a long-term, multigenerational legacy. “It is an honor to receive this distinguished award and be recognized by EY...Learn more
A Big Thanks to America's ToothFairy!
A big thanks to America's ToothFairy! Together, we are working to help kids have a brighter future, saving one smile at a time! Join Septodont North America and America's ToothFairy in our mission of bringing hope and health to kids all around the world! Learn more: https://americastoothfairy.org ...Learn more
Biodentine XP: the new dentin restoration system
Since its launch 10 years ago, Biodentine®, based on Septodont’s innovative Active Biosilicate Technology™ platform, has proven successful in replacing dentin in the crown and in the root. Sold in more than 60 countries and with more than 1000 worldwide publications, Biodentine has saved more than 5 million teeth! Due to its unique features, Biodentine has become a gold standard in preserving tooth structure by offering high bioactivity ...Learn more